Veronique Damagnez

Title: Veronique Damagnez: Innovator in Modulating Dkk-Mediated Interactions

Introduction

Veronique Damagnez is a notable inventor based in Framingham, MA (US). She has made significant contributions to the field of biochemistry, particularly in the area of modulating interactions that are crucial for cellular signaling.

Latest Patents

Damagnez holds a patent for "Reagents and method for modulating Dkk-mediated interactions." This invention provides reagents, compounds, compositions, and methods related to novel interactions of the extracellular domain of LRP5, HBM (a variant of LRP5), and/or LRP6 with Dkk, including Dkk-1. The various nucleic acids, polypeptides, antibodies, assay methods, diagnostic methods, and methods of treatment are related to Dkk, LRP5, LRP6, HBM, and Wnt signaling. These elements are implicated in bone and lipid cellular signaling. The invention offers reagents and methods for modulating lipid levels and/or bone mass, which are useful in the treatment and diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis. Damagnez has 1 patent to her name.

Career Highlights

Throughout her career, Veronique Damagnez has worked with prominent companies such as Wyeth and Oscient Pharmaceuticals Corporation. Her work has significantly impacted the understanding of lipid and bone mass disorders.

Collaborations

Damagnez has collaborated with notable colleagues, including Kristina Allen and Anthony Anisowicz. Their combined expertise has contributed to advancements in their respective fields.

Conclusion

Veronique Damagnez is a pioneering inventor whose work in modulating Dkk-mediated interactions has the potential to influence treatments for various disorders. Her contributions to biochemistry and collaboration with esteemed colleagues highlight her importance in the field.